Wordt geladen...
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia
BACKGROUND: Tobacco smoking is the leading preventable cause of morbidity and mortality in Australia and other developed countries. Of the pharmacological aids that are available for smoking cessation, bupropion (Zyban SR) is eligible for public reimbursement on the Australian Pharmaceutical Benefit...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Group
2007
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2598534/ https://ncbi.nlm.nih.gov/pubmed/17652241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tc.2006.017657 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|